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Summary 
Epidemiological studies suggest that psychiatric comorbidity is widespread and 
common, and most psychiatric patients could be expected to show comorbid patterns of 
psychopathology. Since comorbid disorders are regarded as harder to treat and also plays a 
crucial role for the outcome of psychological treatment, there is of importance to investigate 
how cognitive behaviour therapy, may be adapted to treat complex and comorbid psychiatric 
conditions. The aim of this thesis has been to explore the effectiveness of group and 
individual based cognitive behaviour therapy in treating complex and comorbid psychiatric 
disorders. 
Results suggest that cognitive behaviour therapy seems to make a clinical impact that 
improves symptoms and functioning of patients in the presence of multiple comorbid 
conditions, and different patterns of psychiatric comorbidity with high level of severity could 
be treated effectively using cognitive behaviour therapy both in individual therapy and in a 
group setting.         
 
 3
Acknowledgement 
This study has been carried out at the Department of Psychology, Norwegian University of 
Science and Technology (NTNU), and has been supported by a grant from NTNU.  
I would like to thank and acknowledge the following persons: 
• The patients which have contributed to my research. 
• My supervisor Hans Nordahl, who has introduced me to the field of cognitive 
behavioural therapy, and whose support and enthusiasm has provided me with 
inspiration and motivation during the process of writing this thesis.   
• My supervisor Rolf. W. Gråwe, who has introduced me to the field of research related 
to psychotic disorders, and the significance of psychological research in this area.  
• My colleagues at the PhD forum at the Department of Psychology, NTNU for 
inspiration and feedback during the hard times writing the papers.  
• Finally and most of all, I want to especially thank Eli and my children Markus and Ida 
for being supportive and patient during this period, and for always reminding me 
about the important things in life. 
 4
 
List of papers included in the thesis. 
 
The thesis is composed of 4 articles, referred by their Roman numerals.   
 
I. Hagen, R., Nordahl, H. M., Kristiansen, L., & Morken, G. (2005). A randomised trial of 
cognitive group therapy vs. waiting list for patients with co-morbid psychiatric disorders: 
Effect of cognitive group therapy after treatment and six and 12 months follow up. 
Behavioural and Cognitive Psychotherapy, 33, 33-44. 
 
II. Hagen, R., Nordahl, H. M., & Gråwe, R. W. (2005). Cognitive-behavioural group 
treatment of depression in patients with psychotic disorders. Clinical Psychology & 
Psychotherapy, 12, 465-474 
 
III. Gråwe, R. W., Hagen, R., Espeland, B., & Mueser, K. T. (2007). The Better Life Program: 
Effects of group skills training for persons with severe mental illness and substance use 
disorders. Journal of Mental Health, 16, 625-634 
 
IV. Hagen & Nordahl (2007) Behavioural experiments in the treatment of paranoid 
schizophrenia: A single case study. Accepted for publication in Cognitive and Behavioural 
Practice. 
 
 5
1. 0. Comorbidity. 
For psychiatric disorders, comorbidity emerged as an important issue in classification as 
editions of the DSM/ICD10-manuals over time generated ever narrower and numerous 
diagnoses. With the introduction of DSM-IV (APA, 1994) and ICD-10 (WHO, 1992), it is 
reported an increase in comorbidity among psychiatric conditions. A challenge related to this 
categorical classification is the concept of heterogeneity, meaning that many diagnoses share 
the same symptoms. Heterogeneity and comorbidity are therefore closely linked with each 
other, and without this categorical classification schema there would not be a reason to 
discuss the concept of comorbidity (Maser, Cassano & Michelini, 1997). 
 
The DSM /ICD tendency towards comorbidity could be viewed as allowing for the 
description of the various facets and manifestations of psychiatric illness (First, 2002). 
Although less comorbidity may be desirable to reduce diagnostic complexity, in the absence 
of knowledge about underlying pathophysiology, the trend in successive editions of the 
diagnostic manuals has been to reduce diagnostic hierarchies and increase comorbidity (First, 
2005). It is important to understand that comorbidity in psychiatry does not imply the 
presence of multiple diseases or dysfunctions, but rather reflects our current inability to apply 
Occam's razor (i.e., a single diagnosis to account for all symptoms). 
 
There are different ways to look at the idea of comorbid disorders. For instance comorbidity 
may be defined by the similarity across classes of disorders or by the period of time in which 
the disorders occur (Maser & Cloninger, 1990). In line with this definition, the co-occurrence 
of substance abuse and other mental disorders can be termed a “heterotypic” comorbidity 
(meaning comorbidity between different classes of mental disorders), which may be 
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contrasted with a “homotypic” comorbidity (meaning a comorbidity between different 
members of a general class of mental disorders). An example of a heterotypic comorbidity 
could be the co-occurrence of a depressive disorder in a patient with a diagnosis of 
schizophrenia, while a homotypic comorbidity could for example be the co-occurrence of 
social phobia and generalized anxiety disorder in a patient with comorbid anxiety disorders 
(Hall, Lynskey & Teeson, 2001).  A second definition and distinction could be made between 
“concurrent” and “successive” comorbidity. Concurrent comorbidity is that in which two or 
more disorders are present at the same time, (e.g. schizophrenia and drug dependence), while 
successive comorbidity can be defined as comorbidity in which disorders may occur at 
different times in a person’s life, in ways that may or may not be causally related to each other 
(Hall et al, 2001). Successive comorbidity is also known in the literature as lifetime 
comorbidity (Maser & Cloninger, 1990).  
 
A number of studies have established that clinicians frequently underrecognize comorbidity 
when using unstructured clinical interviews, mainly because the semi-structured interview 
approach to identifying comorbidity has somewhat limited utility for the practicing clinicians, 
because clinicians do not generally have time available to conduct these structured interviews 
(Zimmermann & Mattia, 1999; Basco et al, 2000; Shear et al, 2000; Zimmermann & 
Chelminski 2003; Rush et al., 2005). Clinicians who seek only the diagnostic criteria for a 
specific disorder will probably miss a more global perspective of the entire pathology. Instead 
of a broad field, the clinician only sees a part of the whole picture. Published treatment 
guidelines and manuals reinforce this way of thinking, as they consider treatments for only 
one single diagnosis. One problem with such a classification system and thinking is that it can 
provide the clinician with a false sense of patient homogeneity (meaning all patients with a 
principal diagnosis of X are alike). By definition, categorical models of classification assume 
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the existence of homogenous groups with little overlap. Patients within a particular diagnostic 
group can be quite heterogeneous, largely influenced by their comorbid symptoms.  
 
The DSM- IV (APA, 1994) and the ICD-10 (WHO, 1992) does not suggest specific 
treatments for each disorder category and subcategory. However, modern treatment 
researchers have attempted to design treatments tailored to specific DSM/ICD-10 diagnostic 
categories. In this way comorbidity presents a challenge not only to the official nomenclature, 
it also presents a similar challenge to treatments designed and targeted for the same diagnostic 
categories (Maser, Cassano & Michelini, 1997).  This way of looking at psychopathology 
influence treatment studies that try to examine the efficacy of psychotherapeutic treatments, 
because participants usually have been carefully screened to identify a homogenous group 
with a single psychiatric disorder. Almost all treatment outcome studies today investigate the 
efficacy of a treatment within a group of patients with one specific diagnosis, and either 
exclude or ignore comorbidity (Sanderson & McGinn, 1997). Such a design of doing 
treatment-studies tends to overestimate treatment effects, because patients with comorbid 
conditions often have been excluded. Randomized controlled trials are also complicated by 
comorbidity, because comorbidity can either act as a confounder and threaten the internal 
validity, or as an effect modifier threatening the internal and external validity of these studies 
(Groot, Beckerman, Lankhorst & Bouter, 2003). 
1.2 The prevalence of comorbid disorders 
Based on several epidemiological studies on comorbidity, diagnostic overlap seems to be the 
rule rather than the exception (First, 2005). Prevalence studies of diagnoses in both clinical 
samples and general population samples show that comorbidity among psychiatric disorders 
is highly common (Kessler, 1997). The Epidemiologic Catchment Area-study (ECA) was the 
first to document that comorbidity is widespread in the general population (Robins & Regier, 
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1991). Over 54 percent of respondents in this study, who had a lifetime history of at least one 
DSM-III psychiatric disorder, were found to have a second diagnosis as well. Similar results 
as reported in the ECA-study have also been found in the National Comorbidity Survey 
(NCS). In the NCS-study, 56 percent of the respondents with a lifetime history of at least one 
DSM-III- R disorder also had one or more additional psychiatric disorders (Kessler et al., 
1994). Results from The National Comorbidity Survey-Replication (NSC-R), using DSM- IV 
diagnoses, are consistent with the ECA and NCS studies (Kessler, Chiu, Demler, Walters, 
2005). Data from a Norwegian psychiatric epidemiological study are also similar to the 
studies mentioned above. The results from this Norwegian study shows that 13 percent of the 
sample had two diagnoses, and 14 percent had three or more diagnoses (Kringlen, Torgersen 
& Cramer, 2001). An interpretation of these epidemiological data could be that since neither 
shared symptoms nor shared risk factors explained the strong co-occurrence between 
disorders, the most likely explanation is that having one disorder puts the affected person at 
risk of developing other disorders (Robins & Regier, 1991; Kessler et al., 1994).  
 
These results mentioned above concern lifetime comorbidity, but maybe of greater clinical 
interest is the joint occurrence of multiple disorders in the same person over a recent interval 
of time. Results show that 45 percent of those who reported one psychiatric disorders as 
assessed in the NCS over a 12-month period, carried multiple diagnoses (Kessler et al., 1994). 
Clinical samples show that high concurrent and / or lifetime comorbidity rates have been 
demonstrated for virtually all Axis I DSM disorders, and the comorbidity rates for the Axis II 
personality disorders are even higher (Clark, Watson & Reynolds, 1995). Research data also 
indicate that comorbidity is not random, because most disorders show systematic comorbidity 
patterns with specific diagnoses or diagnostic classes (Clark et al, 1995). For instance various 
anxiety disorders have found to be strongly comorbid with other anxiety disorders, 
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depression, substance abuse and personality disorder (Zimmermann & Mattia, 1999; Wilk et 
al, 2006)  
 
The results from these different psychiatric epidemiological studies show that psychiatric 
comorbidity is highly prevalent. Results also show that the majority of people who suffer 
from any psychiatric disorder also have a history of at least one other. A comparison of pure 
versus comorbid cases of each disorder assessed in the NCS shows consistently, that 
comorbidity is associated with higher severity of symptoms, and that comorbidity also is 
associated with disorder chronicity (Kessler, Foster, Saunders & Stang, 1995). The NCS 
results also suggest that comorbid disorders are, in general, more severe than pure disorders.  
 
The consequences of psychiatric comorbidity are not confined to increased treatment 
complexity and more severe illness course. Comorbid disorders are associated with greater 
social consequences than pure disorders, and findings suggest that the major societal burden 
of psychiatric disorder falls on people with comorbidity, with nearly 90 percent of NCS 
respondents having a severe 12-month psychiatric impairment reporting a lifetime history of 
three or more comorbid psychiatric disorders (Kessler, 1994: Kessler et al, 1994). The NCS 
data further show that respondents with a lifetime history of psychiatric comorbidity are 
significantly more likely than those with a history of only one disorder to experience 
impairments in a wide range of adult roles, and persons with comorbid disorders are more 
likely to be divorced, socially isolated and unemployed (Kessler et al, 1994). McDermud et al. 
(2001) have also found that comorbidity burden showed the strongest relation to impairment 
over and above the presence of any particular class of disorders.  
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What causes such a high rate of comorbidity among psychiatric disorders is not clear. 
Common causes of either a biological or environmental sort, effects of one disorder could 
affect the onset of other disorders, and the problem related to a categorical classification 
system could probably all work as good hypotheses. However, as Kessler (1997) wrote in 
relation to possible connections; the main impression one got when looking at the 
epidemiological results related to comorbidity is that most disorders are related to most other 
disorders in ways, that are very difficult to sort out. 
 
Based upon these already mentioned findings it could be suggested that persons suffering 
from comorbidity are in need of a more complex and broad treatment, than persons suffering 
from just one psychiatric disorder (Wilk et al., 2006).  In addition, in many contexts assessing 
the severity of the individual’s dysfunction may be of greater importance than specifying the 
precise nature of the disorder (Clark et al, 1995). 
1.3 Summary 
The consistent result from comorbidity studies point to a pragmatically important clinical 
reality, namely that a patient presenting him or her for treatment with a single disorder would 
be the exception rather than the rule. Further, despite the high prevalence of comorbidity 
found in community samples, it is possible that comorbidity is undetected in routine clinical 
practice because of the typical process of establishing diagnoses through clinical interviews. 
  
Even if we have problems finding explanations of the connection between different 
psychiatric disorders, there are a number of reasons why comorbidity should matter:  
1. Since comorbidity seems to be the rule rather than the exception with psychiatric disorders, 
and if we do not take comorbidity into account, we could mistake characteristics of the 
disorder under study for those that are due to an ignored comorbid condition.  
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2. Patients with comorbid psychiatric disorders are often more impaired, suffer greater social 
disability and generate larger social costs. This is probably in part because comorbid disorders 
are not diagnosed and treated, and in part because persons with more than one disorder are 
difficult to treat.  
3. To understand why different psychiatric disorders co-occur may also provide clinicians 
with important opportunities for prevention.  
4. Comorbidity has important implications for treatment. 
 
Owing to the fact that the implications of comorbidity in psychological treatment are of 
crucial importance to the outcome of therapy, and because it affects how psychotherapy best 
could be delivered to handle this complexity, this link will be further looked in to.    
1.4 Implications for psychological treatment.  
Clinicians and researchers are increasingly recognizing the importance of comorbidity in the 
application of therapeutic technique and its impact on efficacy (Clarkin & Levy, 2004). 
Comorbidity is important because it affects a host of variables related to treatment and 
treatment planning.  Evidence suggests that comorbidity have a huge impact on psychological 
treatment, usually resulting in more challenging therapies with poorer outcomes (Roth & 
Fonagy, 2005). Comorbid conditions are also likely to lead to poorer end-state functioning, 
because at the end of treatment patients may continue to exhibit symptomatology related to 
the untreated comorbid condition (Roth & Fonagy, 2005).   
 
Different studies have tried to look for specific client variables that influence the course and 
outcome of psychological treatment (Beutler, Clarkin & Bongar, 2000; Beutler & Harwood, 
2000). One of these specific client variables relates to the complexity of the client’s problems 
(which may be defined as comorbidity). The second variable relates to the duration of the 
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difficulties (i.e. the chronicity, frequency and extent of recurrence), which also relates to the 
concept of comorbid disorders. If the patient’s problems are complex and they have been 
suffering from their psychiatric problems over a long time-period, results suggest that the 
effect of treatment was less good and the patients were also more vulnerable for relapses 
(Beutler et al., 2000).  
 
Such findings create a major problem in the recommendation regarding appropriate treatment 
for patients suffering of psychiatric comorbid disorders. Considering the emerging data on the 
extent and significance on comorbidity, patients who are suffering from multiple diagnoses 
are in need of a comprehensive treatment, and this treatment requires interventions that 
address the patient’s full range of symptoms (Sanderson & McGinn, 1997). This is also 
related to clinical practice where the patient’s response would be maximized if the treatment 
was broadened to address each patient’s entire symptom presentation, instead of focusing and 
treating just one disorder at a time (Wolfe, 1994). This approach would also to some degree 
solve the problem of heterogeneity and treatment implications. Since many of the diagnoses 
share the same symptom representation, maybe a symptom-oriented treatment would be 
effective (Clark et al, 1995).  
 
A therapeutic approach that emphasizes comorbidity and also provide a comprehensive and 
integrated treatment for the patient’s comorbid symptoms, would be a symptom-oriented 
model as an opposed to a diagnosis-based treatment. This shift from a disorder-model to a 
symptom-oriented model has already been applied in the treatment and understanding of 
psychotic disorders, and has successfully accumulated research and treatment approaches 
where the concept of comorbidity also has been included (Gould, Mueser, Bolton, Mays & 
Goff, 2001; Rector & Beck, 2001; Gaudiano, 2005, Rathod & Turkington, 2005; Turkington, 
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Kingdon & Weiden, 2006 Bentall, 2007).  A symptom focused model allows clinicians to 
tailor their treatment to address the specific symptom configuration of each patient, 
maximising treatment efficiency (Sanderson & McGinn, 1997). Also, a treatment model that 
focuses on symptoms may provide more optimal care and prevent relapse to a larger extent 
than treatments that focuses on diagnoses (McGinn, Young & Sanderson, 1995).   
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2.0 Cognitive behavioural therapy. 
2.1 The cognitive behavioural treatment model. 
Cognitive- behavioural therapy (CBT) is a psychological approach that has a symptom - 
focused perspective, and could be used with patient suffering from multiple diagnoses.  
In addition to having a focus on the patient’s individual comorbid symptoms, CBT is also 
formulation driven, which could be beneficial both in the understanding and treatment of the 
patient’s comorbid symptoms (Tarrier, 2006). As a contrast to a diagnosis-based model, 
which is based on a categorical way of thinking, the CBT approach facilitates the 
customization of treatment on a more individual basis, and could therefore be more successful 
in treating complex and comorbid problems.  
 
The generic model of CBT is applied to most psychological disorders. According to Beck 
(1976), CBT should be: 
1) Based upon a cognitive model that describes the onset and maintenance of the disorder 
being treated;  
2) Formulation driven;  
3) A structured process;  
4) Based on shared problems and goals;  
5) Educational, allowing the client to understand the process of therapy;  
6) Utilising guided discovery as the engine for change;  
7) Involve homework tasks; and finally  
8) Be time-limited.  
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Based on the notion that cognitions plays a role in the maintenance of most psychiatric 
disorders, cognitive behavioural interventions seek to reduce distress and enhance adaptive 
coping by changing maladaptive beliefs and providing new skills. The various approaches 
differ somewhat in the extent whether they emphasize cognitive mechanisms at the sacrifice 
of more behavioural ones (Hollon & Beck, 2004). The goal of the cognitive-behavioural 
interventions is to change maladaptive beliefs, using a wide range of techniques. These 
techniques include elements of self-monitoring, identifying and challenging negative thoughts 
and assumptions that maintain problematic behaviour and experiences, de-catastrophization, 
scheduling activities, and behavioural experiments that in turn aid further self-monitoring and 
challenge dysfunctional beliefs (Wright, Basco & Thase, 2005) 
  
2.2 The efficacy of cognitive-behavioural therapy. 
CBT appears to be effective for a broad range of clinical and medical disorders, and moreover 
there are numerous indications that the cognitive and cognitive-behavioural interventions may 
produce more lasting changes than other interventions.  A review of 16 meta-analyses shows 
large controlled effect sizes found for CBT for unipolar depression, generalized anxiety 
disorders, panic disorders with or without agoraphobia, social phobia, posttraumatic stress 
disorder, and childhood depressive and anxiety disorders (Butler, Chapman, Forman & Beck, 
2006). Effect sizes for CBT for marital distress, anger, childhood somatic disorders, and 
chronic pain were in the moderate range. CBT was somewhat superior to antidepressants in 
the treatment of adult depression, and was equally effective as behaviour therapy in the 
treatment of adult depression and obsessive compulsive disorder. Large uncontrolled effect 
sizes were found for bulimia nervosa. Disorders such as substance abuse, bipolar disorders, 
psychotic symptoms, personality disorders, and anorexia nervosa are among the disorders 
receiving recent empirical attention regarding the effectiveness of CBT (Butler et al., 2006). 
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Comorbidity  has been found to impact treatment response to cognitive-behaviour therapy 
negatively. Overall, patients with comorbid conditions responded less robustly to CBT, 
though the degree of impact differed between studies (Brown, Antony & Barlow, 1995; 
Erwin, Heimberg, Juster & Mindlin 2002; Newman, Mosfitt, Caspi & Silva, 1998). Equally 
striking in these studies of comorbidity and CBT, were the fact that despite the presence of 
multiple conditions, CBT nonetheless made a significant clinical impact that improved 
symptoms and functioning (Barlow, Allen & Choate, 2004).  
2.3 Modalities of cognitive- behavioural therapy.  
Although cognitive therapy was originally developed as an individual therapy, the approach 
has also been applied to groups. Cognitive-behaviour group therapy (CBGT) may be defined 
as therapy that uses the dynamics of the group format, in addition to the common cognitive 
behavioural therapy techniques to change distorted, maladaptive, and dysfunctional beliefs, 
interpretations, behaviours, and attitudes (Bieling, McCabe & Antony, 2006). The format of 
CBGT could be psycho-educative in nature, being open-ended or manualized. The frequency 
and duration of session in CBT-groups can vary considerably, depending on the choice of format 
and other patient-dependent variables. The number of participants in CBT-groups differs, 
but a number of 6-8 persons are usually regarded as maximum, with the exception of
psycho-educational groups where the number of participants could be larger (Morrison, 2001).  
 
Group therapy has been associated with many advantages, such as potential time and cost 
savings per patient, the possibility of treating a greater number of people, and reducing 
waiting lists. The effects of group cohesion, imitative behaviour, interpersonal learning, and 
opportunity for group members to serve as group therapist and offer mutual support, are 
claimed positive by-products of group treatment (Morrison, 2001; Yalom, 1995). Group 
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settings are also said to provide group members with the opportunity to recognise and share 
common experiences with other group members (Yalom, 1995). However, there are also 
many disadvantages associated with group therapy. These include the risk of one patient 
monopolizing therapy, confrontation between group members, and the development of 
subgroups. Group settings may also impact the group members to become more reluctant to 
discuss disturbing cognitions, and as a result of this fail to undertake and challenge these 
distressing cognitions (Morrison, 2001; Yalom, 1995). Advantages of cognitive behavioural 
groups compared to individual CBT, includes the opportunity to demonstrate the relationship 
between thoughts and feelings through the negative thoughts of the group members, and 
recognize the cognitive distortions of others, which could help the reattribution of their own 
cognitions (Bieling et al., 2006). 
 
Early studies of CBGT focused mainly on depression, but over time group therapy has been 
extended to other areas in line with the evolvement of cognitive behavioural therapy models 
for others disorders, such as anxiety disorders, eating disorders, schizophrenia, bipolar 
disorders, substance disorders, etc. (Bieling et al., 2006). A conclusion based on Morrison’s 
review (2001) and Petrocelli’s meta-analysis (2002) is that for the most part there is little 
difference in results between CBGT and individual CBT treatment studies. However, 
depending on the client group, for example patients who are more severely impaired, more 
depressed, or have an OCD or social phobia disorder, the advantages of an individual 
approach sometimes outweighs the advantages of a group condition (Morrison, 2001).  
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3.0 Objectives and outline of the thesis. 
As seen from the introduction comorbidity plays a crucial role in the outcome of 
psychological treatment. Comorbidity is of great importance regarding the wellbeing of 
people suffering from different concurrent psychiatric disorders, and it is important to explore 
how these problems could be treated from a CBT-point of view. The main objective of this 
thesis is to empirically explore the effectiveness of group and individual based cognitive 
behavioural therapy in treating complex and comorbid psychiatric disorders. The objectives 
for each paper were as follows: 
 
Paper I. A randomized trial of cognitive group therapy.  
In the literature, few studies have tested the effect of cognitive group therapy on a 
heterogeneous sample of patients with psychiatric disorders. In particular, patients with 
anxiety, depression, and cluster C personality disorders are comorbid conditions that the 
clinicians frequently encounter which are sometimes are difficult to treat. The aim of this 
study was to assess the effectiveness of cognitive therapy in a group format (CBGT) with a 
sample of heterogeneous psychiatric disorders.     
 
Paper II. Cognitive behavioural group therapy of depression in patients with psychosis.    
Comorbidity between depression and psychosis is common, but the literature is rather sparse 
related to psychological treatments of depression in patients with concurrent psychotic 
disorders. The aim of the study was explore the effects of CBGT for depression with 
schizophrenic and schizoaffective disorders.  
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Paper III. Group skills training for persons with severe mental illness and substance use 
disorders.  
There is a growing consensus regarding the critical ingredients of effective group 
interventions for persons with co-occurring mental disorders and substance use disorders. 
Based on these clinical consensus and guidelines, “The Better Life Program” was developed 
and manualized to help individuals who suffer from this pattern of psychiatric comorbidity. 
The primary goal of this study was to evaluate the effect of the “The Better Life Program” on 
substance use and mental health outcomes.      
 
Paper IV. Behavioural experiments in paranoid schizophrenia.  
The empirical support for using CBT to treat psychotic symptoms has been widely 
established. This paper reflects the symptomatic complexity of a psychotic patient suffering 
from depression, substance abuse, and psychotic symptoms. The aim of the paper is to show 
how behavioural experiments could be used to change delusional thinking in a patient with 
schizophrenia, and also to discuss ideas for future research in CBT for psychotic symptoms.   
 
Conclusion and shared objectives in the papers. 
All the papers in this thesis involve the empirical investigation on the effect of cognitive 
behavioural therapy in both individual therapy and group therapy settings, to see if this 
approach could be an effective aid to both treat and understand comorbid disorders. The 
fundamental components of CBT, which have been emphasized in this thesis, related to the 
treatment of comorbid conditions are (Barlow et al, 2004);  
(1) trying to change cognitive appraisals of events,  
(2) reduce emotional and behavioural avoidance and,  
(3) facilitate action that counters negative emotional states.  
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Instead of treating concurrent disorders in a sequential manner, a more integrated treatment 
approach is used. This perspective in treating comorbid disorders draws on a tradition that 
focuses on common cognitive behavioural techniques (Wright, Basco & Thase, 2005), and a 
formulation-based approach to CBT (Persons, 1989; Tarrier, 2006).   
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4.0 Method.  
4.1 The samples. 
The papers in this thesis are based on four samples. Below is a closer description of these 
patient samples.  
4.1.1 Sample 1.  
49 participants were referred from psychologists and psychiatrists working at the psychiatric 
in-patient clinics or the psychiatric outpatient clinics at the St. Olav Psychiatric University 
Hospital in Trondheim. Patients with psychosis, substance abuse, suicidal behaviour and 
cluster A or cluster B personality disorder were excluded. Three patients were excluded 
because they fulfilled these criteria, leaving 46 remaining participants. All of the participants 
were assessed with the Structured Clinical Interview for the DSM-IV on axis I and axis II. 
Thirty two subjects completed eight weeks of therapy. There were 22 % males, and 78 % 
females in this sample, with an age range from 20 to 60 (M = 38.12, SD = 10.21). The sample 
that completed therapy fulfilled the criteria of 73 diagnoses based on the SCID- interview, 
with sixty four diagnoses on Axis I, and nine diagnoses on Axis II. The most common 
diagnoses were anxiety disorders, followed by depressive disorders. Sixty four percent used 
psychopharmacological medication in at least six months before they started therapy. See 
table 1 for further description of the sample. 
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Table 1: The patients’ age, sex, and diagnoses in sample 1. 
 Waiting list controls 
(n=17) 
CBGT  
(n=15) 
Total  
(N=32) 
Age (Mean, SD) 38.82 (11.57) 37.33(8.76) 38.12 (10.21) 
Sex (n)    
Females  14 11 25 
Males  3 4 7 
Diagnoses (n)    
Anxiety disorders 28 17 45 
Depressive disorders 9 7 16 
Eating disorders 1 2 3 
Cluster C personality disorders 6 3 9 
Total Axis I 38 26 64 
Total Axis II 6 3 9 
Total number of diagnoses 44 29 73 
Note: Each patient could receive more than one diagnosis. 
4.1.2 Sample 2.  
19 participants were included from psychiatric in-patient clinics or psychiatric outpatient 
clinics at the St. Olav Psychiatric University Hospital in Trondheim. Two participants 
dropped out of therapy. A sample of 17 completed the eight weeks of therapy. Eighty percent 
of the sample were males, and twenty percent females, with an age range from 20 to 47 (M 
=32.6, SD = 7.99). Diagnostic assessments were made by an experienced psychiatrist and an 
experienced psychologist. Eighty percent of the sample had a diagnosis of schizophrenia, and 
the remaining 20 percent had a diagnosis of schizoaffective disorder. All of the participants 
received antipsychotic medication during the study and at follow-up. There was no change in 
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prescribed dosage or type of medication during the trial or in the follow up period. See table 2 
for a further description of the sample. 
 
Table 2: The patients’ age, sex, and diagnoses in sample 2. 
 CBT-group 
(n=17) 
Age (Mean, SD) 32.6 (7.99) 
          Sex (%)  
Females  20 
Males  80 
          Diagnoses ICD-10 (%)   
Schizophrenia 80 
Schizo-affective disorder 20 
 
4.1.3 Sample 3.  
Eighty-two patients from the nine treatment centres in Norway participated in the study. 
Sixty-three patients (77%) completed the treatment. There was an age range from 17 to 54 
(M= 29.90, SD = 7,88).  The samples consisted of sixty eight percent males and thirty-two 
percent females. The most common disorders including a comorbid substance problem were 
psychotic disorders (schizophrenia and schizoaffective disorders), and thereafter personality 
disorders. Diagnoses were set by experienced clinicians at the different centres participating 
in this study. See table 3 for a further description of the sample. 
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Table 3. The patients’ age, sex, and diagnoses in sample 3 
 The Better Life Group 
(n=63) 
Age (Mean, SD) 27.90 (7.88) 
          Sex (n, %)  
Females  20 (32%) 
Males  43 (68%) 
          Diagnoses (n, %)  
* Psychotic disorder   26 (41.3%) 
Non-psychotic disorder  12 (19%) 
Personality disorder   19 (30.2%) 
Unspecified mental disorder  6 (9.5%) 
* Included: Schizophrenia and schizoaffective disorder 
 
4.1.4 Sample 4 
A male with the diagnosis of paranoid schizophrenia (N=1), at the age of twenty-five, with a 
primary diagnosis of paranoid schizophrenia, which at the time of assessment also fulfilled a 
diagnosis of a substance abuse and a moderate depressive episode.  
4.2 Instruments  
Different instruments were used in this thesis including self-reports, interviews, and 
clinicians’ ratings. These measures were:  
4.2.1 Self reports: Symptoms. 
SCL-90-R. Symptom Checklist List -90-Revised (Derogatis, 1983) is a 90 item self 
report, designed to screen for a broad range of psychological problems and distress during a 
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one-week period prior to administration.  Each of the 90 items is rated on a 5-point scale of 
distress ranging from none to extreme. In addition to a total score (General Symptom Index), 
the SCl-90- R yields scores on nine subscales.  The SCL-90-R has evidenced good 
psychometric properties (Bech, Allerup, Maier, Albus, Lavori & Ayuso, 1992; Derogatis & 
Cleary, 1977; Lipman, Covi & Shapiro, 1979).  
 
BDI. The Beck Depression Inventory (Beck, Rush, Shaw, & Emery, 1979) is a 21 item 
self-report inventory, which has been shown extensively to be a reliable and valid measure of 
syndrome depression severity in both clinical and non-clinical populations (Beck, Steer, & 
Garbin, 1988)  
 
BAI. The Beck Anxiety Inventory (Beck, Epstein, Brown & Steer, 1988) is a 21 item 
self-report instrument that measures anxiety severity for the past week, including the day of 
completion. The BAI is established as a reliable and valid measure, and it is recommended as 
a companion instrument to the BDI, particularly for individuals with comorbid depression and 
anxiety (Beck & Steer, 1993a).  
 
BHS. The Beck Hopelessness Scale (Beck, Weissman, Lester, & Trexler, 1974) is a 
20-item self report questionnaire of pessimism and hopelessness. Each item is rated as true or 
false and scores can vary from 0 to 20. Internal consistency of items is satisfactory 
(Cronbach's alpha =.88) (Steed, 2001).  
 
SMAST. The Short Michigan Alcoholism Screening Test (Selzer, Vonokur, van 
Roijen, 1975) is a 13-item list of common signs and symptoms of alcoholism. The subject 
indicates whether he/she has experienced each symptom of problem drinking during his or her 
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lifetime. Item scores are equally weighted and added together to form a total score. Higher 
scores are suggestive of greater alcohol-related problems. The SMAST has been reasonably 
well validated as a measure of alcoholism (Selzer et al., 1975; Harburg et al., 1988). The 
SMAST has yielded adequate reliability estimates with a mean coefficient alpha of 0.93 for 
combined samples of alcoholics and non-alcoholics (Selzer et al., 1975) 
 
DAST. Drug Abuse Screening Test- 20 (Skinner 1982) comprises 20 items assessing 
drug use over the past 12 months, which it yields a quantitative index of problems associated 
with drug use. Good validity and reliability values have been reported for the DAST (Cocco 
& Carrey, 1998; Skinner, 1982; Skinner & Goldberg 1986) 
 
4.2.2 Self reports: Cognitive style and personality traits. 
RSE. The Rosenberg Self Esteem Scale (Rosenberg, 1965) consists of 10 items 
assessing global self esteem, with a range in score from 10 to 40. Previous studies have 
reported acceptable to high reliabilities for the RSE ranging from .72 to .88 (Gray-Little, 
Williams, & Hancock, 1997).  
 
SAS. The Sociotropy-Autonomy Scale (Beck, Epstein, Harrison & Emery, 1983) is a 
60 item self-report inventory, which measures two stable, independent dimensions of 
cognitive traits called sociotropy and autonomy. Thirty items assess sociotropy and 30 items 
assess autonomy. Sociotropy refers to dependent traits, characterized by an intense need for 
love, approval and being esteemed by others. Autonomy is defined as an excessive personal 
demand for accomplishment and freedom from control by others. Test-retest reliability has 
been reported to be overall high for both scales (Robins & Block, 1988) 
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IIP-64. Inventory of Interpersonal Problems 64- Circumplex (Alden, Wiggins & 
Pincus, 1990) is a self-report inventory designed to measure interpersonal problems. The IIP–
64-C has eight scales that form a circumplex of interpersonal problems around the octants of 
dominance and nurturance. This measure shows strong convergence between self-, therapist-, 
and peer-rating profiles. It discriminates between subgroups of depressed and of socially 
anxious clients, and has strong test–retest reliability (total r = .98; average subscale r = .81), 
and acceptable to good alpha coefficients (.72–. 85) (Horowitz, Rosenberg, Baer, Ureno, & 
Villasenor, 1988; Kachin, Newman, & Pincus, 2001) 
 
YSQ. The Young Schema Questionnaire (Young, 1994) is a 205-item questionnaire, 
developed to measure 16 schemas. The items are answered on a six point Likert Scale, 
ranging from “almost never true for me” to “almost always true for me”. In addition to a total 
score, you can also calculate scores on the 16 schemas. The YSQ has demonstrated good 
levels of psychometric properties and clinical utility (Schmidt, Joiner, Young & Telch, 1995; 
Lee, Taylor & Dunn, 1999; Hoffart et al, 2005) 
 
YSQ-SF. The Young Schema Questionnaire-Short Form (Young, 1994) is a 75-item 
questionnaire, developed to measure 15 schemas. The items are answered on a six point 
Likert Scale, ranging from “almost never true on me” to “almost always true on me”. In 
addition to a total score, it is possible to calculate scores on the 15 schemas. The YSQ has 
reported alpha coefficients for the YSQ- SF subscales ranging from .71 to .93. (Glaser, 
Campbell, Calhoun, Bates, & Petrocelli, 2002)  
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MCMI-III. The MCMI-III (Millon, 1994) includes personality disorder scales and 
scales for more prevalent Axis I disorders reflecting Millon’s multiaxial model (Millon & 
Davis, 1997). It consists of 24 clinical scales, as well as three modifier scales. Since its 
introduction in 1977, the MCMI has become one of the most widely used and researched 
clinical assessment instruments. 
 
4.2.3 Clinical interviews.  
SCID I. The Structured Clinical Interview for the DSM-IV on axis I (First, Spitzer, 
Gibbon & Williams, 1995) is a structured interview developed to assess DSM-IV diagnoses 
most commonly seen by clinicians, and includes the diagnostic criteria for these disorders 
with corresponding interview questions. The SCID-I is divided into six self-contained 
modules that can be administered in sequence: Mood episodes; psychotic symptoms; 
psychotic disorders; mood disorders; substance use disorders; and anxiety, adjustment, and 
other disorders.  
 
SCID II. The Structured Clinical Interview for DSM-IV Axis II Personality Disorders 
(First, Spitzer, Gibbon, Williams & Benjamin 1995) is a structured interview developed to 
assess the 10 DSM-IV Axis II personality disorders as well as depressive personality disorder, 
passive-aggressive personality disorder, and personality disorder not otherwise specified. 
 
CDSS. The Calgary Depression Scale for Schizophrenia (Addington, Addington, & 
Schizzel, 1990) is a structured interview developed to assess symptoms of major depressive 
disorders in patients with schizophrenia. The time frame of interest is typically the two weeks 
before the interview.  Each item includes interview questions and descriptive anchors for 
scoring. The CDSS consists of nine items: Depressed mood, hopelessness, self-deprecation, 
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guilty ideas of reference, pathological guilt, morning depression, early awakening, suicide, 
and observed depression. Items are scored 0 = absent, 1 = mild, 2 = moderate, and 3 = severe. 
Total scores range from 0 to 27. A total score of 5 identifies individuals at high risk for a 
major depressive disorder. The items on the CDSS are all typical depressive symptoms and do 
not appear to overlap with the negative symptoms of schizophrenia (Addington, Addington, & 
Maticka-Tyndale, 1992). Reliability of the CDSS has been reported in several studies 
(Addington et al., 1992; Lancon, Auquier, Reine, Toumi, & Addington, 1999; Mueller et al., 
1999; Kontaxakis et al., 2000). The internal consistency appears to be good for both inpatients 
and outpatients, with Cronbach’s alphas ranging from 0.7 to 0.9 (Addington et al., 1990).    
 
GAF. Psychosocial functioning was assessed by the Global Assessment of Functioning 
Scale (American Psychiatric Association, 1994). The GAF is a single measure ranging from 
0-100, with higher scores represents better functioning. The instrument has shown to be 
reliable and valid in a sample of severely mentally ill (Jones, Thornicroft, Dunn, & Coffey, 
1995).  
   
4.2.4 Clinical ratings.  
AUS and DUS. The Alcohol Use Scale (Mueser et al, 1995) and the Drug Use Scale 
(Mueser et al, 1995) are 5-point scales based on the DSM- IV criteria for alcohol and drug use 
disorders, rated for the worst period over the past 6 months (1 = no use, 2 = use with 
impairment, 3 = abuse, 4 = dependence, and 5 = dependence with institutionalization). 
 
 SATS-R. The Substance Abuse Treatment Scale- Revised version, (Mueser, Noordsy, 
Drake & Fox, 2003) is a measure of the patient’s motivation to change, and progress in 
changing his or her substance use behaviour. The score is selected from one of the following 8 
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stages of treatment: Pre-engagement (1), engagement (2), early persuasion (3), late persuasion 
(4), early active treatment (5), late active treatment (6), relapse prevention (7), and in 
remission or recovery (8). The SATS-R is based on the patient’s pattern of substance use over 
the last 6-month period, with an emphasis on the patient’s most recent substance abuse and 
involvement in treatment.  
 
DDFS. The Dual Disorder Fidelity Scale (DDFS) (Mueser, Fox, Bond, Salyers, 
Yamamoto & Williams, 2003) is a 20-item scale assessing the adequacy of specific evidence-
based practices for treatment of individuals with dual disorders. The scale is organized around 
seven principles: integration of assessments and treatment of both disorders, 
comprehensiveness of services, assertive outreach services, applying a harm-reduction model, 
long-term treatment, stage-wise and motivation-based treatment, and using multiple treatment 
modalities (e.g., individual- and group psychosocial strategies, pharmacological strategies). 
Ratings is based upon a review of 10 randomly selected treatment records of patients with 
dual disorders and an interview of a representative sample of clinicians at each centre. Each of 
the 20 items in the DDFS is rated on a 5-point scale (1=not implemented to 5=fully 
implemented). Each item-score has descriptive anchors based on clinical expert sources and 
research. The total score, which is the sum of all 20 items, reflects the degree of 
implementation of evidence based treatment, namely: Score 24-49; not implemented 50-78; 
moderately implemented 63-100; fully implemented. 
4.3 Ethical considerations 
In all of the studies, patients gave their informed consent to participate in the trials, and the 
studies in this thesis have been approved by the Research Ethics Committee, Midt-Norge. 
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5.0 Overview of the studies and the main results. 
5.1 Paper I. A randomized trial of cognitive group therapy vs. waiting list for 
patients with comorbid psychiatric disorders: Effect of cognitive group therapy 
after treatment and six and twelve months follow up.   
In paper I we wanted to investigate if CBGT would be superior to a waiting list in the 
treatment of comorbid psychiatric disorders. The study included 46 patients from the 
psychiatric inpatient’s clinic and the psychiatric outpatient’s clinic at the St. Olav University 
Psychiatric Hospital in Trondheim. The patients were assessed with the Structured Clinical 
Interview on Axis I and Axis II (SCID I + II).  After the diagnostic interview they were 
randomly assigned, either to a cognitive behavioural group therapy (CBGT) program or a 
waiting list (WL). The aims of the study were to assess the effectiveness of cognitive 
behaviour therapy in a group format in a sample of comorbid, non- psychotic psychiatric 
disorders, and also to assess if the effectiveness was upheld at six and twelve months follow 
up. The participants who were in to the CBGT- condition received 8 weeks of treatment, with 
two sessions each week, in all a total of sixteen sessions of ninety minutes duration. The 
participants who were randomly assigned in to the WL- condition waited eight weeks before 
they entered treatment and went through the same program as the CBGT- condition. Thirty-
two participants completed the cognitive-behaviour group therapy.  
 
The results show that an 8-week program of CBGT performed better than the WL with 
respect to symptom relief at post-treatment, especially for anxiety and depression. On the 
other inventories measuring interpersonal stress, sosiotropy/dependency, and maladaptive 
schemas, no significant differences were found between these two conditions at post-
treatment. Depression and general psychiatric distress showed a significant reduction from 
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pre-treatment to post-treatment for all the subjects that completed CBGT. Follow up results 
showed a strong significant reduction on the general symptom level at both six and twelve 
months follow up. Interpersonal distress, maladaptive schemas, and sosiotropy/dependency 
showed no significant differences from pre to post-treatment for the patients who completed 
the program, but interpersonal problems, maladaptive schemas, and sosiotropy/dependency 
were significantly lower after the six months follow up, compared to pre-treatment. The 
sosiotropy/dependency score also showed a significant reduction at twelve months follow up. 
In sum, the study showed that an eight weeks program of CBGT, seems to have a favourable 
effect both on short-term and long-term results. The study also indicates that cognitive- 
behaviour therapy can be conducted in a group format aimed at treating patients suffering 
from comorbid states of anxiety and depression.  
 
5.2 Paper II. Cognitive behavioural group treatment of depression in patients 
with psychotic disorders. 
In paper II we wanted to investigate if CBGT could be effective in treating patients with 
comorbid depressive and psychotic disorders. The study included 19 patients who were 
included from psychiatric in-patient clinics or psychiatric out-patient clinics at the St. Olav 
University Psychiatric Hospital in Trondheim. The inclusion criteria for participation in the 
study were the following: First, having a diagnosis of schizophrenia or schizoaffective 
disorders, second a minimum duration of one year in having these diagnoses, and thirdly a 
comorbid depression in addition to the diagnosis of schizophrenia or schizoaffective 
disorders. Diagnostic assessments related to the schizophrenia and schizoaffective disorders 
were made by an experienced psychiatrist and an experienced psychologist. The primary 
target of the study was to assess if CBGT would reduce the depressive symptoms, and 
secondly to assess whether CBGT could reduce hopelessness and increase self-esteem and 
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psychosocial functioning, and thirdly to examine any changes of personality traits and 
maladaptive schemas connected with the comorbidity in depression and psychosis. In all 17 
patients completed the eight weeks of CBGT. The group members received eight weeks of 
treatment, with two sessions each week, in all 16 sessions of 90 minutes duration. 
 
The results showed that an eight week program of CBGT had a significant effect on treating 
depression in schizophrenic disorders, both at post-treatment and at six months follow up, 
with no incidents of relapse. Also, the psychosocial functioning measured by GAF showed a 
significant increase from pre-treatment to the six months follow up for the participants, but 
there were no significant changes in hopelessness or self-esteem. Three of the scales on the 
MCMI-III regarding clinical personality patterns showed significant changes at post 
treatment, with a significant decrease in the scales of Compulsive and Negativistic, and a 
significant increase on the Narcissistic scale. At the six months follow up there were no 
significant changes on the MCMI-III scales. Results regarding personality-traits and 
maladaptive schemas connected with the co-morbidity in depression and psychosis, revealed a 
high prevalence of avoidance, dependency, depressive thinking, and anxiety among the 
patients in the sample. The results from the YSQ also supported this trend. To summarize the 
findings, the study showed that CBGT had been effective in treating depressive symptoms 
and improving psychosocial functioning, but had been less effective in reducing hopelessness, 
increasing self-esteem, changing maladaptive schemas, or decreasing psychotic symptoms 
within the group participants.  
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5.3 Paper III. The Better Life Program: Effects of group skills training for 
persons with severe mental illness and substance disorders.  
In paper III the primary goals were to evaluate the feasibility of the Better Life program, to 
examine its effects on substance use and mental health outcomes, and to explore individual 
predictors of outcome. Patients with dual disorders at nine centres in Norway were recruited 
to participate in a study related to The Better Life program. The inclusion criteria for 
participation in the Better Life group program were: Minimum 18 years of age, having a 
severe mental disorder with accompanying functional impairment, and alcohol or drug misuse 
(i. e., substance use resulting in problems related to self-care, relationships, legal or health 
problems or exacerbation of their mental illness). Eighty-two patients participated in the 
study.  The mean number of scheduled sessions was thirty-seven, and the mean participation 
rate was thirty-two sessions.  
 
The results showed that the Better Life program was associated with a low drop-out rate and 
that participants significantly improved in drug and alcohol use severity as well as their stage 
of substance abuse treatment. Clinicians’ ratings of alcohol and drug abuse/dependence on the 
AUS and DUS indicated that about one half of the patients with alcohol or drug use disorders 
were in stable remission at the end of the program. Furthermore, patients’ self-ratings of 
changes in substance use on the DAST and SMAST corroborated the clinicians’ ratings. In 
addition, program participants demonstrated significant improvements in global psychosocial 
functioning from pre-treatment to post-treatment. The positive results associated with the 
participation in the Better Life program are in line with several other group interventions for 
patients with dual disorders.      
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5.4 Paper IV. Behavioural experiments in the treatment of paranoid 
schizophrenia: A single case study.  
In paper IV we wanted to investigate if behavioural experiments could be used as a powerful 
tool to change the delusional thinking in a patient with a diagnosis of paranoid schizophrenia. 
In addition to highlighting the use of behavioural experiments as means to change the 
patient’s delusional thinking, the paper also tries to demonstrate how techniques of cognitive 
behavioural therapy can be adapted in treating patients with psychotic symptoms. Finally, 
some suggestions for research to explore the use of behavioural experiments in cognitive 
therapy of psychosis are suggested.  
 
The results demonstrated that CBT, and in particular behavioural experiments, can be used 
with good results in treating a patient suffering from comorbid symptoms of substance abuse, 
depression, and psychotic symptoms. Although behaviour experiments are considered as a 
really important part of CBT for psychosis, there has been little attention related to research 
on how to best utilize it in CBT for psychotic symptoms. The paper therefore suggest that 
future research to a larger extent should examine behavioural interventions in contrast to more 
pure cognitive interventions, to find out what makes CBT in psychosis effective.   
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6.0 Summary of the thesis 
6.1 Main results from the studies 
Paper I shows that CBT has a favourable effect on both short- and long- term results, and also 
indicates that CBT in a group format could be used to treat patients suffering from comorbid 
states of anxiety and depression. Paper II shows that an eight-week program of cognitive 
behaviour group therapy had a significant effect on treating depression in schizophrenic 
disorders, both at post treatment and at six months follow up, with no incidents of relapse. 
Although there was a decrease in depression, the CBGT had no effect on the psychotic 
symptoms. This study indicates that CBGT could be effective in treating comorbid depression 
in schizophrenic disorders. Paper III shows that a group intervention focusing on motivational 
enhancement interventions and skills training had an effect on both substance abuse and 
mental health outcomes. This study indicates that a CBGT focusing on motivational 
interviewing and skills training is a promising psychological intervention with people 
suffering from substance abuse and psychiatric disorders. Paper IV demonstrates that CBT 
could be effective in treating a patient suffering with comorbid disorders of depression, 
substance abuse and delusional disorders. This study indicates that especially behavioural 
experiments could be an effective element in CBT for psychosis.  
 
Overall, the studies indicate that both individual and group CBT may bed adapted effectively 
to treat complex comorbid disorders, and have acceptable effects. Other main results could be 
summarized as follows: 
• Results from the studies indicate that CBGT fall in line with other studies showing 
that cognitive group therapy is effective in treating psychiatric problems.  
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• Results from the studies illustrate that CBT could be useful in treating patients with 
psychosis.  
• CBT seems to make a significant clinical impact that improves symptoms and 
functioning in the presence of multiple comorbid conditions.  
• All the studies appear to support the idea that different patterns of psychiatric 
comorbidity could be treated effectively using a more general trans-diagnostic CBT- 
approach. 
 
6.2 Limitations of the studies 
There are some potential limitations of the studies. These limitations will briefly be 
mentioned in the following:  
• Two of the studies (Paper II & III) did not include a no-treatment control group, which 
could influence the internal validity of these results. Without a control group it is 
difficult to determine whether the observed change is related to the treatment effect of 
CBT, or other treatments the patients were receiving, spontaneous recovery, or the 
natural course of the patients’ disorder. The use of randomized controlled trials is 
needed to address these questions in a proper way.   
• Two of the studies (Paper II & Paper III) had a lack of a blind assessment which could 
act as a threat to the external validity of the results. It is essential to keep the rater 
“blind” and independent, and if this condition is not maintained, scoring can be 
affected by observer or rater expectations. It is possible that the clinicians’ judgement 
of improvement was influenced by their expectation and beliefs regarding the effect of 
CBT.   
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• In two of the studies (Paper II & III) there was a lack of a diagnostic structured 
interview, which could be a threat to the internal validity of the results. It is important 
to ensure that the patients who participate in a study fulfil the criteria of a diagnosis 
which serve as an inclusion to a treatment study. The best way to ensure these 
demands is the use of a structured diagnostic interview.     
• Finally, there could be a threat to validity related to the use of self-reports in the 
studies. One phenomenon often observed in clinical trials is called the hello-goodbye 
effect, where patients tend to exaggerate their symptoms at the beginning of therapy 
and to minimize the symptoms at the end, probably to please the therapist or obeying 
demand characteristics related to the study. Nordahl (1999) also reported that self-
report questionnaires seem to be influenced by a patient’s actual mood, which could 
affect the psychometric properties in some of the self-reports used in the studies.  
 
Despite these limitations related to control groups, the lack of blind assessment, structured 
diagnostic assessment, and the use of self-reports, the results of the studies in this thesis have 
strong ecological validity. Patients treated in the studies are typical and representative for 
patients treated in clinical practice, where the occurrence of comorbidity and heterogeneity of 
disorders is a common problem. Many modern treatment outcome studies typically exclude or 
ignore comorbidity. Thus, the studies included in this thesis that include comorbid patients, 
will maybe reflect the “real-world” conditions for clinicians in a better way than randomised 
controlled trials for single disorders.  
6.3 Implications of the findings 
The key to managing comorbid conditions seem to be to recognize this complicated problem 
by trying to assess the patient’s mental health problems as broadly as possible. Further, it is 
important to use the clinical information to determine a treatment plan that best identify the 
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multiple disorders and maximize potential changes in all of them. The final point in treating 
comorbid problems would be to choose a type of treatment that could be tailored and 
individualized to the patient’s comorbid conditions. Since CBT place an emphasis on an 
individualized case formulation of a patient’s complex problems, CBT seem to best adapted 
to treat these comorbid psychiatric conditions. However, to use CBT in treating complex 
comorbid disorders, some basic principles are fundamental, and these have been emphasized 
in the studies: 
 
I. The first component is to learn to the patients to identify and restructure their negative 
appraisals, which leads to a more objective appraisal of distressing situations. 
II. The second component focuses on the exposure to distressing situations, and shows 
that approaching instead of avoidance could lead to change in cognitions and distress. 
III. The third component is that successful treatment involves changing usual behaviours 
that undermine coping and functioning. The implementation of new coping skills and  
 behavioural experiments could be useful in facilitating such change 
 
The epidemiological data on comorbidity seem to challenge the meaningfulness of the classic 
psychotherapeutic research paradigm, where researchers try to identify a group of individuals 
who share one common diagnosis and then examine them on variables hypothised to be 
relevant to the aetiology, course, or treatment of the disorder. Research has shown us rather 
thoroughly that pure, uncomplicated cases are highly uncommon, and maybe to study such 
patient populations does not represent a good pathway of therapy research. Even more 
important is the fact that even if non-comorbid cases can be identified, they are likely to be 
atypical and less representative of the overall population of individuals with the disorder. To 
produce ecologically valid psychotherapeutic outcome studies, there is maybe a need of a 
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shift from emphasizing controlled psychotherapy outcome studies on single disorders, to 
include more naturalistic psychotherapy outcome studies, which may heighten ecological 
validity, and reduce the gap between psychotherapy research and clinical practice (Werbart, 
1989, Birchwood 2006).  
 
The research on the effect of CBT for comorbid disorders is still in its infancy, and the 
tailoring of CBT to different types of comorbid disorders will be a major area of interest in the 
coming years. The evolution of metacognitive therapy which emphasize shared cognitive 
processes in psychology across disorders, is an expansion of CBT in such a direction (Wells, 
2000; Wells. 2007) 
 
6.4 Main points of the thesis.  
 Comorbidity is the rule than the exception. Epidemiologic studies suggest that 
psychiatric comorbidity is widespread and common, and most patients could be 
expected to show comorbid patterns of psychopathology. 
 Comorbidity should be assessed by structured diagnostical interviews. 
 In most studies of the effect of psychotherapy, patients with significant levels of 
comorbidity are excluded. Results from these studies do not give indications for 
treatment of patients with comorbid disorders.  
 There are rather few results on the effect of CBT on complex and comorbid 
psychiatric disorders.  
 A trans-diagnostic case formulation based CBT-approach to complex and comorbid 
psychiatric disorders seems to be useful, both in group and single-case formats.    
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Abstract 
Since the first description of cognitive therapy of paranoid delusions, the empirical support 
for cognitive behavioural therapy in treating psychotic symptoms has been widely established. 
The aim of the present case study is to show how the behavioural experiment can be used as a 
powerful tool to change delusional thinking in a patient with paranoid schizophrenia. In 
addition to highlighting the use of behavioural experiments to change the patient’s delusion, 
we will illustrate various cognitive techniques that can be adapted to treat patients with 
psychotic symptoms.  
 
KEYWORDS: Cognitive behavioural therapy, psychosis, delusions, auditory hallucinations, 
behavioural experiments.
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Introduction 
Since the first description of cognitive therapy of paranoid delusions, (Beck, 1952), 
the empirical support for using cognitive behavioural therapy (CBT) to treat psychotic 
symptoms has been widely established (Gould, Mueser, Bolton, Mays & Goff, 2001; Rector 
& Beck, 2001; Dickerson, 2004; Gaudiano, 2005; Rathod & Turkington, 2005; Turkington, 
Kingdon  & Weiden, 2006). Previously psychosis was considered a biological condition 
insusceptible to psychological interventions, however, more recent research has shown that 
positive symptoms are on a continuum with normality and therefore may be susceptible to the 
same cognitive behavioural therapy techniques used to treat anxiety and depression (Kuipers 
et al., 2006; Bentall 2007). The cognitive model of psychosis conceptualises a combination of 
factors that shape and maintain positive symptoms such as delusions and auditory 
hallucinations (Garety, Kuipers, Fowler, Freeman & Bebbington, 2001), where reasoning and 
attributional biases may play a particular role in symptom formation and the maintenance of 
these symptoms (Freeman & Garety, 2004; Bentall 2003; Frith 1992).  
The primary goals when using CBT to treat psychosis are to teach the patient to 
identify and monitor their thoughts and assumptions in specific situations, and to evaluate and 
correct these thoughts and assumptions against objective external evidence and actual 
circumstances. Challenging delusional thinking may stimulate the patient to come up with 
more functional alternatives (different phases of CBT in psychosis see figure 1).  
 
----------------------------------------------------------------------------------------------------------------- 
Figure 1 approximately here 
----------------------------------------------------------------------------------------------------------------- 
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Delusional beliefs and auditory hallucinations are based upon thoughts and 
assumptions that the patient believes to be true and real, and they are held with great intensity 
and preoccupation. These beliefs cause distortions in the processing of new information, 
which also maintains the patient’s delusional beliefs and auditory hallucinations. Evidence to 
challenge delusional cognitions may be gathered in a variety of ways (Chadwick, Birchwood, 
& Trower, 1996; Fowler, Garety & Kuipers 1995; Nelson 2005; Morrison et al., 2002, 2004, 
Kingdon & Turkington, 2005). Behavioural experiments and verbal strategies such as the use 
of automatic thought records and guided discovery are strategies that can be used to gather 
this evidence.  The three main purposes of using behavioural experiments to treat psychotic 
symptoms are to formulate a testable and specific assumption, to test the reliability of this 
assumption, and to construct new and more functional assumptions and beliefs (Rouf et al., 
2005). The designs commonly used in behavioural experiments are formal hypothesis testing, 
(if so …what will happen ...), or investigative or discovery-oriented methods (What will 
happen if…?). Behavioural experiments can therefore be used to test the reality in the 
patient’s distorted interpretations. Reality testing includes setting up situations for the specific 
purpose of producing evidence that is directly relevant to the delusional belief, or to find 
evidence for an alternative belief (Nelson, 2005). Provided that these reality tests are properly 
set up, the evidence against a delusion or auditory hallucination can be very persuasive. In 
using reality tests, it is important to build alternative explanations that can counterbalance the 
patient’s delusional beliefs, and thereafter use evidence to support these alternative 
explanations. When these possible alternatives and supporting evidence are well prepared, the 
patient’s delusional interpretations can be tested (Close & Schuller, 2004) 
The aim of the present case study is to show how the behavioural experiment can be 
used as a powerful tool to change delusional thinking in a patient with paranoid 
schizophrenia. In addition to highlighting the use of reality testing as a means to change the 
 5
patient’s delusional interpretations, we will also try to show how techniques of cognitive-
behavioural therapy can be adapted to treat patients with psychotic symptoms.  
 
Case presentation and symptoms 
In order to protect patient anonymity, a number of essential details have been altered 
in this case study.  The patient gave his consent in an early phase of the therapy, that his case 
story could be used as a presentation. Tony is 25 years old. He is a single, Caucasian male, 
who was hospitalised with a diagnosis of paranoid schizophrenia. The patient has a younger 
brother, and his parents divorced when he was a child. The patient and his brother were taken 
into care due to gross neglect by their parents and put in to a foster home when he was seven 
years old. During his childhood years he had regular contact with his biological mother, but 
did not meet his biological father again until the age of seventeen. Shortly after the death of 
his father, Tony started using drugs (cannabis, amphetamine and ecstasy) and started to drink 
heavily. Despite Tony’s apparent heavy substance abuse he completed college with 
satisfactory results. After graduation from college, he enrolled in some courses at the 
university, but did not attend any of the lectures and failed all of his exams. During these 
years he developed a severe substance abuse. The last year before hospitalisation Tony lived 
on unemployment benefits, but also dealt drugs to support his drug use. He was never arrested 
for dealing drugs.  
 At the age of twenty-two he became psychotic. At the time of admission to the 
psychiatric hospital he was experiencing psychotic symptoms in the form of auditory 
hallucinations and delusions. His voices told him that he should be killed when the right 
opportunity presented itself, and also that he was kept under surveillance by the police. His 
appraisal of the voices was that they were policemen haunting him because of his history of 
selling drugs. He was certain that these policemen had put a contract out to kill him. His 
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delusional ideas were of a paranoid form. Tony mentioned several persons by name who 
worked in the anti-narcotic squad that he thought were involved in this conspiracy to kill him. 
Tony believed that these policemen were using various methods of surveillance to keep him 
under their control. Among his delusional ideas was that he was being used for an experiment. 
He believed receivers had been implanted in his head, and that the policemen were using 
radio beams to over-stimulate his brain, which caused him pain. He was certain that his head 
would explode if this “torture” continued. He had strong delusional convictions about the 
damage to his brain that was caused by the radio beams. Tony consistently insisted that more 
physical tests ought to be taken because of his conviction that something was physically very 
wrong with him. There was a link between the auditory hallucinations Tony experienced and 
his delusional ideas of radio beams. He was convinced that the voices he heard were 
transferred by the policemen’s radio transmitter to the implants in his head, which was his 
proof that the voices were inflicted on him by an outside agency.  
After Tony had been at the acute ward for three weeks he was transferred to a ward for 
young people suffering of psychotic disorders. Though he had not been using narcotics since 
hospitalisation he still experienced auditory hallucinations, had delusional ideas, and 
responded poorly to the antipsychotic drugs (olanzapine) he was administered. The therapist 
undertook a structured diagnostic interview (SCID I and II).  Based on the SCID-interview 
and information from the patient, Tony was diagnosed with a paranoid schizophrenia. The 
patient also met SCID I criteria for diagnoses of substance abuse and a current moderate 
depressive episode. The comorbid symptoms of substance abuse and depression are rather 
common in patients suffering from psychotic disorders (Michail & Birchwood, 2007; 
Kavanagh & Mueser, 2007), but differentiating schizophrenia from schizoaffective disorders 
and mood disorders with psychotic features can sometimes be particularly difficult (Frances 
& Ross, 2005). Tony’s psychotic symptoms in the form of bizarre delusions had been present 
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for at least six months before he was admitted to the psychiatric hospital, and his mood 
symptoms were not a significant part of Tony’s symptom presentation. The depressive 
symptoms that the patient experienced could probably best be understood as a psychological 
reaction to his delusional ideas and auditory hallucinations. Based on this information the 
occurrence of a mood disorder with psychotic features and a schizoaffective disorder could be 
ruled out. The psychotic symptoms Tony experienced persisted even though he had stopped 
drinking alcohol and smoking cannabis the last month before the assessment took place. This 
indicates that the psychotic symptoms were probably not a direct physiological result from the 
substances he had been using. In addition, the symptoms he experienced could not be 
explained merely by intoxication or withdrawal.  
 
Case formulation 
The assessment of Tony suggested that the delusions and auditory hallucinations he 
experienced were mixed with his symptoms of depression and substance abuse. Morrison’s 
model of development and maintenance of voices was used to make a formulation of Tony’s 
auditory hallucinations (Morrison, 2001). In his model Morrison suggests that different 
internal or external triggers result in the patient hearing voices, and that the voices may be 
interpreted as threatening for the voice hearer. The catastrophic interpretations of the voices 
result in increased negative mood and physiological arousal, and elicit safety-seeking 
behaviours and hypervigilance because the patient feels threatened by the voices. This 
behaviour can increase the future frequency of auditory hallucinations, and also prevent the 
disconfirmation of the threat presented by the voices (therefore maintaining distress and 
anxiety).  
In Tony’s case, the substance abuse and anxiety (thoughts of threat) seemed to be 
triggers for hearing voices. The voices said that he would be harmed and that a contract had 
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been put on his head. Tony believed that these voices belonged to a policeman who he once 
knew, and who he thought had the power to make this happen. The voices triggered feelings 
of depression and anxiety, and he tried to help himself by using substances and by staying 
home to avoid potential attacks. This form of safety behaviour maintained the auditory 
hallucinations, and probably increased the frequency of the auditory hallucinations. The 
pattern of Tony’s coping behaviour resulted in a vicious circle: When the intensity of negative 
emotions (depression and anxiety) increased, Tony craved large amounts of alcohol, 
amphetamine, and cannabis, which in turn increased his auditory hallucinations. This pattern 
also illustrates what is known as the stress-vulnerability hypothesis of schizophrenia, where 
stress combined with a psychological vulnerability produce the symptoms characteristic of 
psychosis (Zubin & Spring, 1977; Neuctherline & Dawson, 1984). 
Freeman, Garety, Kuipers, Fowler & Bebbington (2002) cognitive model of 
persecutory delusions also guided Tony’s case formulation. Freeman et al. (2002) hypothesise 
in their model that anxiety and depression play a direct role in symptom development and the 
maintenance of persecutory delusions. They suggest that emergence of psychotic symptoms 
depends upon an interaction between vulnerability and stress (such as drug use). People who 
experience symptoms, such as voices, will search for a reason for their anomalous experiences 
by drawing upon pre-existing beliefs about the self, others, and the world. The delusions will 
be maintained because disconformatory evidence could be discarded (e.g. by the use of safety 
behaviours) and confirmatory evidence for the delusions is obtained (e.g. confirmation bias, 
attention bias, and the tendency to jump to conclusions).  
The powerful, threatening nature of his voices and the somatic torment he experienced 
were Tony’s evidence for his delusional ideas. He experienced his life situation as hopeless, 
because he believed that no one could help him against his external enemies, which made him 
feel depressed. He started to withdraw from others because he was unable to sort out who was 
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not a threat to him. The social isolation lead to a viscous circle of depression and substance 
abuse which seemed to increase his delusional beliefs and auditory hallucinations (see figure 
2 for a case formulation). 
 
 
----------------------------------------------------------------------------------------------------------------- 
Figure 2- approximately here 
----------------------------------------------------------------------------------------------------------------- 
 
Based on the current case formulation it was probable that many of the symptoms 
Tony experienced were based on his appraisal of his voices (persecutory delusions, 
depression, and substance abuse), and that the main focus of treatment had to be directed 
toward working with these catastrophic misinterpretations. In order to work with Tony’s 
auditory hallucinations, it would be important to directly test the content and reality of the 
voices (Chadwick & Birchwood 1994; Birchwood & Chadwick 1997; Byrne, Birchwood, 
Trower & Meaden, 2006). In treating Tony’s delusions of persecution the goals were to 
evaluate his evidence for being under surveillance by the police through verbally challenging 
these ideas and then testing these beliefs by using behavioural experiments. A final goal for 
the therapy was to construct alternative explanations of his experiences that did not cause 
emotional distress.  
 10
 
Treatment 
The patient was treated by one of the authors, a clinical psychologist (HMN), in an 
inpatient ward at the university psychiatric hospital. The therapist is a well-trained CBT-
therapist with over fifteen years of experience in conducting cognitive behavioural therapy.   
The patient received a combination of therapy, two sessions a week of CBT over a period of 6 
months and medication (Olanzapine, 15 mg).  In the first stage of the cognitive behavioural 
therapy the emphasis was to engage the client and form a therapeutic alliance that would 
allow for a collaborative approach (Kingdon & Turkington, 2005). The process of 
normalisation can be used as a therapeutic tool towards forming this alliance, and can also 
pave the way for a collaborative formulation helping the client to be an active part in his 
treatment (Dudley et al, 2007). Based on the cognitive model, the experience of distress due 
to psychotic symptoms becomes understandable. Studies show that this process is one of the 
most important components of successful cognitive behavioural therapy for psychosis 
(Dudley et al, 2007). In this process the therapist discussed in an empathic and genuine 
manner Tony’s psychotic expression, and together they worked on finding an explanation of 
how these symptoms had been shaped and maintained, based on the cognitive models of 
auditory hallucinations and persecutory delusions. In this phase, by discussing the patient’s 
symptoms from a normalising stance, a strong therapeutic alliance was formed between Tony 
and the therapist.     
 Based on the cognitive case formulation the treatment was to have three focal points. The 
first focal point was to treat the patient’s substance abuse due to the negative impact it would 
have on the patient’s psychiatric symptoms, the second was to challenge the patient’s 
appraisal of the voices, and the third was to find disconfirmatory evidence for Tony’s 
persecutory delusions.  
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In the treatment of the patient’s substance abuse, techniques from motivational 
interviewing were implemented. Motivational interviewing is a set of therapeutic strategies 
designed to help the patient understand the impact of substance abuse on their lives in their 
own terms (Miller & Rollnick, 2002). Studies using extended cognitive behavioural therapy, 
which addresses both substance use disorders and serious mental illness tend to have a good 
outcome on both of the disorders (Barrowclough et al, 2001; Haddock et al; 2003), though 
gains of an integrated treatment have shown decay over time (Barrowclough et al., 2001). 
Interventions in this phase of Tony’s therapy were focused on showing the discrepancy 
between Tony’s personal goals and his current substance abuse, in an effort to motivate him 
to reduce his substance abuse behaviour. In a non-confrontational manner and using a 
collaborative approach, Tony’s personal goals were identified and explored. His main goal in 
life was to either get a job or to continue his disrupted education. The therapist explained to 
the patient how the viscous circle of the substance abuse behaviour maintained the patient’s 
psychiatric symptoms, and gradually Tony started to see that there was a contradiction 
between his life goals and his substance use. He understood that if he continued his pattern of 
drinking and taking drugs to solve his problems, his symptoms would get worse.  
The therapist explained to him the cognitive model of relapse in substance abuse. To 
counter further relapses, the patient’s automatic thoughts and permissive beliefs in these high- 
risk situations for using substances were examined (Beck, Wright, Newman & Liese, 1993). 
To avoid relapses Tony received psycho-education about urges and cravings and learned how 
to make use of cognitive-behavioural techniques to fight urges and cravings (Graham et al, 
2004). After this phase of motivational interventions, his substance abuse decreased. 
Although there was a considerable reduction in his consumption of alcohol and drugs, Tony 
experienced two minor relapses in his substance abuse later in therapy. These occurred when 
the patient was on leave from his psychiatric ward. On these leaves he chose to smoke 
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cannabis with some old friends, which increased his psychotic symptoms, though they were 
not as dramatic as his initial symptoms. To prevent new relapses antecedents and triggers for 
his substance behaviour in these relapse situations were examined, and coping strategies 
discussed.   
After working through his problems related to his substance abuse, the therapy focus 
shifted to trying to modify Tony’s safety behaviours. These safety behaviours maintained his 
appraisal of his auditory hallucinations, and prevented disconfirmatory evidence of the 
persecutory delusions. Due to his paranoid ideation, he felt that both the other patients and the 
nurses who were working at the ward were a threat to him. Treatment was directed towards 
making Tony feel safer in his surroundings and to overcome his social isolation, which had 
become safety behaviour for him (and reinforced his depressive and anxious symptoms). 
Because Tony spent most of his time in bed, he felt useless and inactive. To fight these 
negative cycles of inactivity and social isolation, the therapist and Tony scheduled activities. 
Activity scheduling is a standard cognitive behavioural therapy technique proven to be 
effective in treating depressive symptoms (Person, Davidson, Tompkins, 2000), and can also 
be effective in treating psychotic symptoms (Kingdon & Turkington, 2005).  Tony and the 
therapist planned activities he could do during the week: He took part in activities with other 
people in the ward (for instance making food), and participated in a work-out group in a gym 
near the hospital together with some of the other patients. He was also motivated by the 
therapist to leave the ward on occasion to go to the shops and to the nearby town to meet other 
people. Slowly these interventions made him feel less depressed, although the delusions and 
the auditory hallucinations he experienced still made him anxious.  
 
Reality testing: using a match-mismatch technique 
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In addition to his depressive and anxious symptoms, his auditory hallucinations, and 
his paranoid delusions, the patient also experienced somatic delusions. Tony was especially 
concerned that his pituitary gland was destroyed because of the radio beams he been exposed 
to from the police. His assigned homework related to these belief, was to evaluate his own 
beliefs about his pituitary gland against anatomic information about the pituitary gland. He 
searched for information in medical textbooks and on the Internet about the pituitary gland,   
and how it functioned. The therapist asked Socratic questions about comparing the symptoms 
of a damaged pituary gland with his own symptoms. Although this new knowledge weakened 
Tony’s delusion of being physically harmed, he still continued to believe that he was being 
exposed to radiation because he still heard voices and continued to suffer from his bodily 
pain.  
 
Behavioural Experiment: Increase-decrease manoeuvre 
In order to protect himself against the radiation, he had put several bottles of water 
under his bed together with some aluminium foil. These were seen as safety behaviours, 
because Tony believed the water and the aluminium foil could deflect the radio beams. This 
delusion was tested out in a behavioural experiment by using an increase-decrease technique. 
An increase-decrease procedure is based on a simple behavioural experiment, where the first 
part is based on what will happen if you increase the use of safety behaviours (less beams - 
weaker voices) and the second is based on what will happen if the safety behaviours are 
removed (more beams - stronger voices). The behavioural experiment was done over the 
course of two nights. The first night the patient was instructed to put more bottles of water 
under his bed to see if this caused him to hear fewer voices. On the second night this 
procedure was reversed; some of the bottles were removed to see if this resulted in hearing 
more voices. The patient found out there was no connection between the amount of bottles of 
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water he had put under his bed and the intensity of his auditory hallucinations. Tony then 
stopped these safety behaviours because the evidence from the reality test suggested that it did 
not have any effect on the intensity of his auditory hallucinations.  
 
Behavioural Experiment: Challenging the voices 
Tony’s auditory hallucinations, however, still caused him a lot of distress. Challenging 
his appraisals of the voices was the next step.  First, the therapist used Socratic questioning to 
find out more about the content of Tony’s voices, so the foundation for a behavioural 
experiment to challenge the omnipotence and truthfulness of these voices could be laid. 
Secondly as a behavioural experiment, Tony started to register how often the voices were 
correct in their predictions about him (e.g.: Why haven’t I been harmed or killed yet?”, “Do 
the voices lie to me?”, “How often have the voices been correct in their threats to me”)? 
Based on these registrations, Tony began to get doubts regarding how truthful the voices 
were. He started to see the voices as phoney, which stated things that hadn’t come true.  
Confronting the omnipotence Tony had attributed to his voices using this technique made him 
feel more empowered, and he started thinking that he had more control than he originally had 
thought he could have. In line with Morrison’s model of auditory hallucinations, Tony 
experienced that the voices became less distressing.  The voice’s frequency and intensity was 
reduced, because he now perceived them as lies trying to disturb him. Tony managed by 
detaching more and more from the voices to handle the presence of the voices, and discovered 
that the voices disappeared for a short period over some days, which he found very strange. 
 
Behavioural Experiment: Emotional reasoning 
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After challenging the patient’s interpretation of the power and control of the voices, 
the cognitive behavioural therapy shifted towards reality testing some of Tony’s delusional 
beliefs (see table 1 for behavioural experiments used in CBT with Tony).  
----------------------------------------------------------------------------------------------------------------- 
Table 1 approximately here 
----------------------------------------------------------------------------------------------------------------- 
In a collaborative manner Tony and the therapist set up behavioural experiments to 
evaluate the validity of his beliefs of being persecuted and under surveillance. Together with 
the therapist, Tony formulated his beliefs about someone observing him and his level of 
convictions related to these beliefs. To examine these beliefs further the therapist and Tony 
checked the parking lot where Tony insisted that he had seen suspicious persons sitting in a 
car. Tony and the therapist did this behavioural experiment every time Tony saw cars that he 
found suspicious. When reviewing the behavioural experiments, the role of anxiety in 
maintaining delusions was discussed, and Tony was able to understand how high levels of 
anxiety could serve as strong confirmatory evidence even in the absence of external evidence 
(i.e.. emotional reasoning).  
 
Behavioural Experiments: Radio waves  
Further behavioural experiments were set up, and because Tony’s delusions were 
closely connected to his appraisal of the voices, a new behavioural experiment was carried 
out. Tony was still certain that the voices came from outside his head, and were inflicted upon 
him by radio beams, though he had begun to understand that they didn’t tell him the truth.  To 
help him understand that the voices were not caused by radio beams, the therapist and Tony 
agreed to test the hypothesis “the voices are externally inflicted”. Tony and the therapist 
agreed that if the voices were caused by radio beams, then he would not hear them if he was 
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in a room that blocked out all radio beams and mobile phone signals. If Tony still heard the 
voices in such a room, it would be evidence suggesting that the voices did not come from 
outside by radio beams, but rather took place inside his head. In trying to test the hypothesis, 
the therapist and Tony used a cellular phone and a radio and went in search of a room that 
could not receive signals. After visiting several places in the city, the therapist located a bomb 
shelter from World War II where they made sure that no signals from the mobile phone or 
radio-programs could be received. It is noteworthy that Tony seemed to be comforted by 
being in a shelter where the resistance had hid during the war. After staying in this facility for 
one hour Tony discovered that he still heard the voices. His response, for several minutes, was 
confusion and silence. After this behavioural experiment he reported feeling less threatened 
by the police. The delusions of being persecuted were still there, but the levels of anxiety and 
depression were clearly diminishing. The results of the behavioural experiments seemed to 
motivate Tony to continue critically investigating his thoughts and the nature of the voices.  
 
Behavioural Experiment: Setting up a confrontation 
Next, the therapist approached Tony’s belief that a particular policeman led the 
persecution of him. This policeman had worked in the drug-squad. Tony believed that because 
he had sold drugs this policeman hunted him. Tony’s delusion was based on an actual person, 
so the policeman (now living in another city) was contacted to see if he would meet with 
Tony. The therapist explained the background for this rather peculiar request to the 
policeman, and he agreed to meet them to answer specific questions Tony had prepared for 
him. The meeting was set up as a behavioural experiment, and Tony was given two tasks: To 
prepare concrete questions for the meeting, and to hypothesize how the policeman would 
look, behave, speak and answer his questions. The questions and hypotheses with the 
expected outcome were formulated as a questionnaire prior to the meeting. A tape recorder 
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was used during the meeting to ensure accuracy in later discussions between the therapist and 
Tony. As anticipated from the therapist’s phone call with the police officer, the officer proved 
to be competent and understanding, and had no problems handling Tony’s questions and 
accusations. The meeting resulted in Tony becoming more certain that this policeman could 
not be a part of the plot against him. He seemed to be relieved by this.     
Tony’s response to this behavioural experiment was monitored by a questionnaire 
developed for the experiment by both the therapist and the patient. The patient’s symptoms of 
stress, voice-hearing, and delusions were recorded once a month, once a week and one hour 
prior to the behavioural experiment. Further more the same registrations took place one hour 
after and one week after the behavioural experiment. The results can be seen in table 2, and 
show a rather unexpected shift in some of the delusional content. He experienced a shift from 
thinking that the voices were telling him the truth and was threatening, to that they are 
mendacious and the threats empty. However he still reported in this questionnaire that he 
believes that the voices are beyond his control and that the voices come from outside his head. 
Tony still felt that the voices had the same intensity; he was still convinced that the voices 
were inflicted on him from outside, and that they were beyond his control. However, he felt 
safer and doubted that the police were actually after him. Clinical observations suggested that 
Tony was less anxious and depressed than before the therapy started. The questionnaire made 
especially for this behavioural experiment, only measured change in cognitions for a time 
period of one week after the confrontation with the policeman had taken place. There are 
therefore no measures related to changes in Tony’s appraisal of localization and control of the 
voices after this time period. We do know from clinical practice and research that cognitive 
restructuring needs time to take place, and Tony’s history after the termination of therapy, 
shows that his cognitions about the control of the voices and localization have been altered as 
a result of the cognitive behavioural therapy. 
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----------------------------------------------------------------------------------------------------------------- 
Table 2 approximately here 
----------------------------------------------------------------------------------------------------------------- 
In retrospect, we see that the meeting between the policeman and the patient was very 
important and useful for the patient. Tony was pleased to take an active part testing his 
assumptions and fears. The cognitive behavioural therapy used with this patient emphasized 
to actively test reality in a simple and straightforward way. This made Tony receptive for a re-
evaluation of his strongly held delusional beliefs and reappraisal of the voices. In therapy, 
Tony’s delusional thinking was challenged, which stimulated him to explore alternative 
beliefs. The anxiety, depression, and distress caused by his delusions and his appraisal of his 
auditory hallucinations were reduced through these cognitive behavioural techniques.  
         
Discussion 
The case study has illustrated how behavioural experiments can be used to treat delusions and 
auditory hallucinations in a patient diagnosed with paranoid schizophrenia. The models of 
Morrison (2001) and Freeman et al. (2002) provide a good foundation for formulation to 
guide the treatment. The principles of cognitive behavioural therapy using Socratic 
questioning and designing specific targeted behavioural experiments resulted in 
disconfirmatory evidence for Tony’s appraisal of the voices and his delusions were weakened. 
These cognitive changes considerably reduced Tony’s distress and symptoms.  The 
behavioural experiments Tony and the therapist set up used this rationale by presenting new, 
corrective information to be processed. Threat-related cognition that maintained the auditory 
hallucinations and persecutory delusions were changed. The good outcome in this case study 
could be related to different factors. Firstly, the patient and the therapist had an especially 
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good therapeutic alliance which is of crucial importance in doing CBT for psychosis. 
Secondly Tony’s high level of suffering could also be seen as an important motivating factor 
in therapy. Finally, the patient’s high degree of psychological mindedness made him very 
suitable for the rationale of cognitive behavioural therapy. Even if his conviction in his 
delusional beliefs faded as a result of the therapy, he still experienced some level of paranoid 
readiness to other people after termination of therapy. These negative core beliefs could 
probably be seen as a result of an insecure attachment to other people (Gumley, 2007). Some 
months after the termination of therapy, the patient was discharged from the psychiatric ward. 
Together with his case manager Tony and the therapist planned how Tony could build a new 
network, which did not reinforce substance use, and how he could stay well. He has now gone 
back to university to study, and has not yet relapsed.   
 
Limitations and alternative explanations 
The case study has some limitations. First, is the problem of generalisation from single cases? 
Caution is needed to generalise from small sample trials, and in particular from one single 
case.  Second, the use of anti-psychotic drugs may influence the course and the intensity of 
the psychotic symptoms although his medication was kept at a stable dosage throughout the 
whole treatment. Thirdly, it may be difficult to assign all the changes Tony experienced 
during therapy to the behavioural techniques and psychosocial interventions alone. Most 
probably the treatment gains could be assigned to both medication and therapy, but the gains 
from the treatment was so swift and closely related to the interventions that we find the highly 
likely that the behavioural experiments influence on the changes was substantial. However 
this needs to be investigated in a larger trial. Finally, we cannot establish the long-term effect 
of the present approach to the treatment of paranoid schizophrenia based on the current case 
study. This must be considered in future studies. 
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Implications 
Though the empirical support for CBT to treat psychosis has been established, to date there 
has not been a well-controlled trial that has attempted to dismantle the components of CBT 
for psychosis, or to identify the specific mechanisms responsible for treatment effectiveness 
(Gaudiano, 2005). Even if no dismantling studies have been attempted, results suggest that if 
interventions in cognitive behavioural therapy of psychosis are coded as being more cognitive 
or behavioural in nature, behavioural interventions seem to be more effective (Tarrier & 
Wykes, 2004). There have been some attempts to develop theories to explain particular 
elements of change in CBT for psychosis (Beck & Rector 2002; Beck & Rector, 2003; Beck 
2004; Rector, Beck & Stolar, 2005), but we still lack a detailed theoretical and psychological 
understanding of the psychopathological processes in psychosis that could specify these 
changes observed in therapy (Tarrier, 2005). Although behavioural experiments are 
considered a valuable part of cognitive therapy for psychosis, there has been little attention to 
research on how to best utilise it in cognitive behavioural therapy of psychotic symptoms. An 
interesting unanswered question is whether the process of change is best described through 
change in thought content or if it is more a function of metacognitive awareness (Gaudiano, 
2005)? Evidence from different studies has failed to show the specific efficacy of cognitive 
interventions compared to behavioural interventions (Jacobson et al., 1996; McLean et al, 
2001; Borkovec, Newman, Picus & Lytle, 2003). The evidence suggests that the use of 
behavioural techniques is a powerful therapeutic strategy, and that behavioural experiments 
promote great cognitive, affective, and behavioural change (Rouf, Fennell, Westbrook, 
Cooper & Bennett- Levy, 2005). This should also be explored more carefully in psychotic 
disorders. Future research in CBT for psychosis should therefore examine empirically 
supported principles of change; studies using dismantling designs could prove useful for this. 
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It ought to be noted, though, that there are some negative expectations that such a research 
programme could be productive for these purposes (Tarrier & Wykes, 2004; Tarrier 2005).  
A dismantling study, comparing behavioural interventions against more cognitive 
interventions, could indicate whether it is the behavioural interventions or the cognitive 
interventions that make CBT of psychosis effective. With this kind of research as the 
foundation we might be able to create more specific models of the mechanisms involved in 
the aetiology and maintenance of psychotic symptoms and tailor CBT to the different types of 
patients who suffer from psychosis.   
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Table 1. Behavioural experiments used in the cognitive behavioural therapy with Tony.  
Target 
cognitions  
Alternative 
cognitions 
Experiment Results Conclusion 
Paranoid 
ideation:  
 Police wants to 
attack me 
There is no one 
who is trying to 
hurt me.  
Go out to shops 
and the nearby 
gym to see what 
happens 
No one tried to 
hurt me.  
Even if I feel threatened by other 
people, this does not mean that they are 
dangerous.  Some people are also really 
nice to me. 
Going shopping and working out at the 
gym also has a positive effect on my 
depression 
External forces:  
The voices I 
hear comes from 
an external force 
The voices I 
hear are coming 
from inside of 
me. These 
voices can be 
my thoughts. 
Find a room 
where no radio 
beams can enter 
to see if I still 
can hear the 
voices.   
I can still hear 
the voices, 
which means 
that the voices 
are probably 
coming from 
inside of me.  
These voices I hear could be my 
thoughts. Maybe these thoughts make 
me anxious and I hear them as 
externally generated? If these thoughts 
make me anxious, I should find out 
more about them, and try to find out if 
what they say is true 
Somatic 
concerns:  
There is 
something 
wrong with my 
pituary gland 
There is nothing 
wrong with my 
pituary gland.  
My symptoms 
do not fit with 
gland disease 
Read about how 
the pituary gland 
is functioning. 
Search the 
Internet for 
information.   
Even if I feel 
something is 
wrong, it does 
not mean that 
this is a fact.  
If there is nothing wrong with my 
pituary gland, there must be an 
alternative explanation? The bottles of 
water and the aluminium foil I put 
under my bed to protect me from the 
radio beams may be unnecessary. 
Maybe I could put them away and see 
what happens? 
Ideas of 
persecution:  
The police are 
watching me, 
and they have 
put a price on 
my head 
The police are 
not watching 
me. They are 
really not 
interested in me.  
I am just afraid.  
Meet the 
policeman who I 
think is 
responsible for 
the persecution 
of me, and ask 
him questions 
about this. 
The policeman I 
thought was 
trying to kill 
me, was a rather 
nice person. His 
answers were 
reassuring. 
I don’t think the police are trying to kill 
me, and there is not a conspiracy to kill 
me. What is the explanation of the 
voices I hear, and the symptoms I feel 
in my body? Could there be an 
alternative explanation to this? Maybe I 
could explore this? 
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Table 2 Changes in symptoms, appraisal of voices, conviction in delusions before and after 
the behavioural experiment (BE) of meeting the policeman 1 
 How 
anxious 
do you 
feel 
right 
now? a 
How 
depressed 
do you 
feel right 
now? b 
Voices 
coming 
from 
outside 
your 
body? c 
Voices 
beyond 
your 
control? 
c 
Voices 
telling 
you 
the 
truth? c 
Do the 
policemen 
want to 
kill you? c 
Do the 
police 
conspire 
against 
you? c 
Do the 
police 
use 
radiation 
to hurt 
you? c 
Do you 
think the 
policemen 
know 
where you 
live? c 
One 
month 
before 
BE 
8 8 8 8 7 8 8 8 8 
One 
week 
before 
BE 
2 0 8 8 3 5 8 8 8 
One 
hour 
before 
BE  
1 0 8 8 4 6 8 8 8 
One 
hour 
after 
BE 
0 0 8 8 2 0 0 4 0 
One 
week 
after 
the 
BE 
0 0 8 8 0 0 0 0 0 
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Note 1:  Scores in symptoms, appraisal of voices, and conviction in delusions before and after the behavioural 
experiment (BE) 
a 0= not anxious at all, 8= very anxious,  
b: 0 = not depressed, 8= very depressed;  
c: 0 = not certain at all, 8 = very certain it’s true  
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Figure captions  
Figure 1. The different phases in cognitive behavioural therapy of psychosis. 
Figure 2. A cognitive formulation of Tony’s auditory hallucinations. 
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Figure 1. The different phases in cognitive behavioural therapy of psychosis.  
Engage the patient in therapy, and create a therapeutic alliance.  
↓ 
Normalization of psychotic symptoms.  
↓ 
Develop and share a case formulation with the patient  
↓ 
Working with delusions: Try to reality test the delusions by using behavioural experiments. 
Work with the patient to develop alternative explanations.  
Working with auditory hallucinations: Reality test the appraisal of the voices, working with 
coping strategies related to hearing voices, restructure alternative explanations.  
↓ 
Relapse prevention.  
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Figure 2. A cognitive formulation of Tony’s auditory hallucinations. 
 
 
 
Triggers: 
Smoking cannabis 
Thoughts of being persecuted 
Mood and arousal: 
Anxiety and low 
mood, hyper vigilance 
Hearing a voice: 
“We are watching 
you” 
Avoidance and safety 
behaviour: 
Stays at home, using 
substances
Appraisal: 
The police are going to hurt me 
